• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们目前对代谢综合征和心房颤动有哪些了解?

What do we currently know about metabolic syndrome and atrial fibrillation?

机构信息

Department of Cardiology, University Clinical Hospital Centre "Dr Dragisa Misovic" (Tadic), Belgrade, Serbia; Clinic of Cardiology (Ivanovic), Clinical Centre of Serbia, Belgrade, Serbia; Clinical Research Unit (Cuspidi), University of Milan-Bicocca and Istituto Auxologico Italiano, Meda, Italy.

出版信息

Clin Cardiol. 2013 Nov;36(11):654-62. doi: 10.1002/clc.22163. Epub 2013 Jun 20.

DOI:10.1002/clc.22163
PMID:23788255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6649365/
Abstract

Metabolic syndrome represents a cluster of atherogenic risk factors including hypertension, insulin resistance, obesity, and dyslipidemia. Considering that all of these risk factors could influence the development of atrial fibrillation, an association between atrial fibrillation and the metabolic syndrome has been suggested. Additionally, oxidative stress and inflammation have been involved in the pathogenesis of both metabolic syndrome and atrial fibrillation. The mechanisms that relate metabolic syndrome to the increased risk of atrial fibrillation occurrence are not completely understood. Metabolic syndrome and atrial fibrillation are associated with increased cardiovascular morbidity and mortality. Because atrial fibrillation is the most common arrhythmia, and along with the prevalence of metabolic syndrome constantly increasing, it would be very important to determine the relationship between these 2 entities, especially due to the fact that the risk factors of metabolic syndrome are mainly correctable. This review focused on the available evidence supporting the association between metabolic syndrome components and metabolic syndrome as a clinical entity with atrial fibrillation.

摘要

代谢综合征是一组动脉粥样硬化危险因素的聚集,包括高血压、胰岛素抵抗、肥胖和血脂异常。由于所有这些危险因素都可能影响心房颤动的发生,因此有人提出心房颤动与代谢综合征之间存在关联。此外,氧化应激和炎症参与了代谢综合征和心房颤动的发病机制。将代谢综合征与心房颤动发生风险增加相关联的机制尚不完全清楚。代谢综合征和心房颤动与心血管发病率和死亡率增加有关。由于心房颤动是最常见的心律失常,而且随着代谢综合征的患病率不断增加,确定这两者之间的关系非常重要,特别是因为代谢综合征的危险因素主要是可以纠正的。本综述重点介绍了支持代谢综合征各组成部分以及代谢综合征作为一种临床实体与心房颤动之间关联的现有证据。

相似文献

1
What do we currently know about metabolic syndrome and atrial fibrillation?我们目前对代谢综合征和心房颤动有哪些了解?
Clin Cardiol. 2013 Nov;36(11):654-62. doi: 10.1002/clc.22163. Epub 2013 Jun 20.
2
What is the role of metabolic syndrome and obesity for postoperative atrial fibrillation after coronary bypass grafting?代谢综合征和肥胖对冠状动脉旁路移植术后心房颤动的作用是什么?
BMC Cardiovasc Disord. 2019 Jun 17;19(1):147. doi: 10.1186/s12872-019-1130-3.
3
Lifestyle modification in the prevention and treatment of atrial fibrillation.生活方式改变在心房颤动预防和治疗中的作用
Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):117-25. doi: 10.1016/j.pcad.2015.07.001. Epub 2015 Jul 13.
4
Cardiometabolic risk factors and atrial fibrillation.心血管代谢危险因素与心房颤动。
Rev Cardiovasc Med. 2013;14(2-4):e73-81. doi: 10.3909/ricm0693.
5
Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic.代谢综合征、心房颤动和中风:应对新兴的流行疾病。
Heart Rhythm. 2015 Nov;12(11):2332-43. doi: 10.1016/j.hrthm.2015.06.038. Epub 2015 Jun 30.
6
Postoperative atrial fibrillation: incidence, mechanisms, and clinical correlates.术后心房颤动:发生率、机制及临床关联
Cardiol Clin. 2014 Nov;32(4):627-36. doi: 10.1016/j.ccl.2014.07.002. Epub 2014 Aug 28.
7
Meta-analysis of metabolic syndrome and its individual components with risk of atrial fibrillation in different populations.代谢综合征及其各组分与不同人群心房颤动风险的荟萃分析。
BMC Cardiovasc Disord. 2021 Feb 15;21(1):90. doi: 10.1186/s12872-021-01858-1.
8
Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease.地中海饮食:打破心房颤动与代谢综合征和非酒精性脂肪肝关系的工具。
Nutrients. 2022 Mar 16;14(6):1260. doi: 10.3390/nu14061260.
9
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).欧洲心律协会(EHRA)/欧洲心血管预防与康复协会(EACPR)关于如何预防心房颤动的立场文件,该文件得到了心律协会(HRS)和亚太心律协会(APHRS)的认可。
Eur J Prev Cardiol. 2017 Jan;24(1):4-40. doi: 10.1177/2047487316676037. Epub 2016 Nov 4.
10
The impact of lifestyle intervention on atrial fibrillation.生活方式干预对心房颤动的影响。
Curr Opin Cardiol. 2018 Jan;33(1):14-19. doi: 10.1097/HCO.0000000000000470.

引用本文的文献

1
Can the Atherogenic Index of Plasma (AIP) Be a Prognostic Marker for Good Clinical Outcome After Mechanical Thrombectomy for Acute Ischemic Stroke?血浆致动脉粥样硬化指数(AIP)能否作为急性缺血性卒中机械取栓术后良好临床结局的预后标志物?
Diagnostics (Basel). 2025 Apr 8;15(8):947. doi: 10.3390/diagnostics15080947.
2
L-shaped association of plasma low-density lipoprotein cholesterol with atrial fibrillation recurrence after catheter ablation: a prospective cohort study.血浆低密度脂蛋白胆固醇 L 型与导管消融后心房颤动复发的相关性:一项前瞻性队列研究。
Sci Rep. 2024 Nov 18;14(1):28434. doi: 10.1038/s41598-024-79836-8.
3
Association between stress hyperglycemia ratio index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective study using the MIMIC-IV database.基于 MIMIC-IV 数据库的回顾性研究:危重症房颤患者应激性高血糖比值指数与全因死亡率的相关性。
Cardiovasc Diabetol. 2024 Oct 14;23(1):363. doi: 10.1186/s12933-024-02462-1.
4
Obesity: the perfect storm for heart failure.肥胖:心力衰竭的完美风暴。
ESC Heart Fail. 2024 Aug;11(4):1841-1860. doi: 10.1002/ehf2.14641. Epub 2024 Mar 15.
5
Estimates of the global, regional, and national burden of atrial fibrillation in older adults from 1990 to 2019: insights from the Global Burden of Disease study 2019.1990 年至 2019 年全球、区域和国家老年人房颤负担的估计:来自 2019 年全球疾病负担研究的见解。
Front Public Health. 2023 Jun 12;11:1137230. doi: 10.3389/fpubh.2023.1137230. eCollection 2023.
6
Evaluation of the Paradoxical Association Between Lipid Levels and Incident Atrial Fibrillation According to Statin Usage: A Nationwide Cohort Study.根据他汀类药物使用情况评估血脂水平与新发房颤之间的矛盾关联:一项全国性队列研究
J Lipid Atheroscler. 2023 Jan;12(1):73-86. doi: 10.12997/jla.2023.12.1.73. Epub 2022 Dec 13.
7
Risk prediction for new-onset atrial fibrillation using the Minnesota code electrocardiography classification system.使用明尼苏达编码心电图分类系统对新发房颤进行风险预测。
Int J Cardiol Heart Vasc. 2021 Mar 31;34:100762. doi: 10.1016/j.ijcha.2021.100762. eCollection 2021 Jun.
8
Genomic and Proteomic Study of the Inflammatory Pathway in Patients With Atrial Fibrillation and Cardiometabolic Syndrome.心房颤动和心脏代谢综合征患者炎症通路的基因组学和蛋白质组学研究
Front Cardiovasc Med. 2020 Dec 2;7:613271. doi: 10.3389/fcvm.2020.613271. eCollection 2020.
9
Monotherapy of experimental metabolic syndrome: II. Study of cardiovascular effects.实验性代谢综合征的单一疗法:II. 心血管效应研究。
Interdiscip Toxicol. 2017 Nov;10(3):86-92. doi: 10.1515/intox-2017-0014. Epub 2018 Feb 14.
10
Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets.心房颤动与非酒精性脂肪性肝病的关联:潜在的共同治疗靶点。
Oncotarget. 2017 Jul 24;8(36):60673-60683. doi: 10.18632/oncotarget.19522. eCollection 2017 Sep 1.

本文引用的文献

1
Statin Use and Risk of Atrial Fibrillation or Flutter: A Population-based Case-Control Study.他汀类药物的使用与心房颤动或心房扑动风险:一项基于人群的病例对照研究。
Am J Ther. 2015 May-Jun;22(3):186-94. doi: 10.1097/MJT.0b013e31827ab488.
2
N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials.N-3 多不饱和脂肪酸预防心房颤动:随机对照试验的更新系统评价和荟萃分析。
J Am Heart Assoc. 2013 Feb 19;2(1):e005033. doi: 10.1161/JAHA.112.005033.
3
Inflammation in atrial fibrillation.心房颤动中的炎症。
J Am Coll Cardiol. 2012 Dec 4;60(22):2263-70. doi: 10.1016/j.jacc.2012.04.063.
4
Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials.他汀类药物治疗与心房颤动:已发表随机对照试验的系统评价和更新荟萃分析。
Curr Opin Cardiol. 2013 Jan;28(1):7-18. doi: 10.1097/HCO.0b013e32835b0956.
5
The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis.他汀类药物治疗对未接受介入性心脏干预的患者新发和复发性心房颤动的预防作用:系统评价和荟萃分析。
Int J Cardiol. 2013 Aug 10;167(3):624-30. doi: 10.1016/j.ijcard.2012.08.056. Epub 2012 Sep 19.
6
Methodology for patient-specific modeling of atrial fibrosis as a substrate for atrial fibrillation.将心房纤维化作为心房颤动基质进行患者特异性建模的方法。
J Electrocardiol. 2012 Nov-Dec;45(6):640-5. doi: 10.1016/j.jelectrocard.2012.08.005. Epub 2012 Sep 19.
7
Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation.心房颤动时心室的氧化应激与微循环血流异常
Front Physiol. 2012 Jul 5;3:236. doi: 10.3389/fphys.2012.00236. eCollection 2012.
8
Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study.脉压与高血压伴左心室肥厚患者新发心房颤动的相关性:降压治疗预防终点事件的洛沙坦干预研究(LIFE)。
Hypertension. 2012 Aug;60(2):347-53. doi: 10.1161/HYPERTENSIONAHA.112.195032. Epub 2012 Jul 2.
9
Higher incidence of atrial fibrillation in the metabolic syndrome: a Hispanic population study.代谢综合征患者中房颤的发病率较高:一项西班牙裔人群研究。
Bol Asoc Med P R. 2011 Oct-Dec;103(4):24-7.
10
Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation.与心房颤动患者肥胖相关的电生理和血液动力学特征。
J Am Coll Cardiol. 2012 Aug 28;60(9):851-60. doi: 10.1016/j.jacc.2012.03.042. Epub 2012 Jun 20.